These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19998427)

  • 1. E-cadherin expression in male urethral smears and correlation with PCR-based detection of human papillomavirus infection.
    Tena-Suck ML; Alarcón A; Rösl F; Astudillo-de la Vega H
    Diagn Cytopathol; 2010 Aug; 38(8):583-9. PubMed ID: 19998427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV involvement in OSCC: Correlation of PCR results with light microscopic features.
    Khangura RK; Sengupta S; Sircar K; Sharma B; Singh S; Rastogi V
    J Oral Maxillofac Pathol; 2013 May; 17(2):195-200. PubMed ID: 24250078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and micronuclei study of human papillomavirus-related oral squamous cell carcinoma.
    Pal P; Raychowdhury R; Basu S; Gure PK; Das S; Halder A
    J Oral Maxillofac Pathol; 2018; 22(3):335-340. PubMed ID: 30651677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes associated with HPV infection in women aged over 50 years: A cross-sectional study from China's largest academic woman's hospital.
    Yue C; Zhang C; Ying C; Jiang H
    Front Endocrinol (Lausanne); 2022; 13():972963. PubMed ID: 36452321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a predictive model for the risk of developing trichomonas vaginitis in women.
    Li Q; Li Y; Bai Y; Zhang H; Zhao W
    Sci Rep; 2022 Nov; 12(1):20182. PubMed ID: 36424393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical Cells.
    Fracella M; Oliveto G; Sorrentino L; Roberto P; Cinti L; Viscido A; Di Lella FM; Giuffrè F; Gentile M; Pietropaolo V; Prezioso C; Palma E; Recine N; Palaia I; Scagnolari C; Antonelli G; Pierangeli A
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36422611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of
    Liu LL; Sun S; Zhang L; Wu QH; Tian LS; Li B; Chen XS; Luo ZZ
    Front Public Health; 2022; 10():1036264. PubMed ID: 36388312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of early diagnosis models for cervical precancerous lesions using large-scale cervical cancer screening datasets.
    Meng B; Li G; Zeng Z; Zheng B; Xia Y; Li C; Li M; Wang H; Song Y; Yu S
    Virol J; 2022 Nov; 19(1):177. PubMed ID: 36335385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
    Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
    PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk.
    Onywera H; Mabunda SA; Williamson AL; Mbulawa ZZA
    Front Reprod Health; 2022; 4():887736. PubMed ID: 36303664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions.
    Speetjens FM; Welters MJP; Slingerland M; van Poelgeest MIE; de Vos van Steenwijk PJ; Roozen I; Boekestijn S; Loof NM; Zom GG; Valentijn ARPM; Krebber WJ; Meeuwenoord NJ; Janssen CAH; Melief CJM; van der Marel GA; Filippov DV; van der Burg SH; Gelderblom H; Ossendorp F
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36261215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
    Ebisch RMF; Rijstenberg LL; Soltani GG; van der Horst J; Vedder JEM; Hermsen M; Bosgraaf RP; Massuger LFAG; Meijer CJLM; Heideman DAM; van Kemenade FJ; Melchers WJG; Bekkers RLM; Siebers AG; Bulten J
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1328-1336. PubMed ID: 36177908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacilli metabolites restore E-cadherin and suppress MMP9 in cervical cancer cells.
    Pawar K; Aranha C
    Curr Res Toxicol; 2022; 3():100088. PubMed ID: 36176311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Performance of the RealTi
    Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
    Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BV associated bacteria specifically BVAB 1 and BVAB 3 as biomarkers for HPV risk and progression of cervical neoplasia.
    Naidoo K; Abbai N; Tinarwo P; Sebitloane M
    Infect Dis Obstet Gynecol; 2022; 2022():9562937. PubMed ID: 35996693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-κB/C-myc.
    Dong B; Huang Y; Cai H; Chen Y; Li Y; Zou H; Lin W; Xue H; Feng A; Zhao H; Lu Y; Gao H; Mao X; Wu Z; Pan D; Sun P
    J Med Virol; 2022 Nov; 94(11):5519-5534. PubMed ID: 35835717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women.
    Hampl M; Hesselink AT; Meijer CJLM; Denecke A; Einhorn I; Reinecke-Luethge A; Geppert CI; Jentschke M; ; Petry KU; Hillemanns P
    Int J Cancer; 2022 Nov; 151(9):1578-1585. PubMed ID: 35666529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later.
    Inturrisi F; Bogaards JA; Siebers AG; Meijer CJLM; Heideman DAM; Berkhof J
    Tumour Virus Res; 2022 Dec; 14():200240. PubMed ID: 35640823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening.
    Heideman DAM; Oštrbenk Valenčak A; Doorn S; Bonde J; Hillemanns P; Gimpelj Domjanič G; Mlakar J; Hesselink AT; Meijer CJLM; Poljak M
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women.
    Xu X; Zhang Y; Yu L; Shi X; Min M; Xiong L; Pan J; Liu P; Wu G; Gao G
    Sci Rep; 2022 Apr; 12(1):6609. PubMed ID: 35459771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.